Related Experiment Videos
[Glycosaminoglycans in syrinogomyelia].
Voprosy Meditsinskoi Khimii
|January 1, 1992
Summary
Glycosaminoglycan (GAG) excretion is significantly reduced in syringomyelia patients, with altered GAG levels in skin, CSF, and brain tissues. This suggests a widespread connective tissue metabolism disorder in the condition.
Area of Science:
- Biochemistry
- Genetics
- Neurology
Context:
- Syringomyelia is a rare neurological disorder characterized by cyst formation within the spinal cord.
- Alterations in glycosaminoglycan (GAG) metabolism have been implicated in various connective tissue disorders.
Purpose:
- To investigate urinary glycosaminoglycan (GAG) excretion patterns in patients with syringomyelia.
- To determine the tissue-specific content of GAG in patients with syringomyelia and compare it with healthy individuals.
Summary:
- Urinary GAG excretion was 2.7-fold lower in syringomyelia patients compared to healthy controls.
- GAG content was reduced in skin (30%), cerebrospinal fluid (40%), and brain (20-40%), but increased by 80% in the affected spinal cord.
- The observed GAG excretion patterns are genetically determined and inherited in a dominant manner.
Impact:
- The findings indicate a significant impairment of connective tissue metabolism in syringomyelia.
- This study highlights the potential role of GAGs as biomarkers for syringomyelia.
- Understanding GAG metabolism alterations may open new avenues for therapeutic interventions in syringomyelia.